Blue Ox Healthcare Partners, LLC - Jul 18, 2022 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
10%+ Owner
Signature
Blue Ox Healthcare Partners, LLC /s/ John A. Neczesny, Secretary
Stock symbol
SERA
Transactions as of
Jul 18, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 05:20 PM
Previous filing
Jul 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SERA Class A Common Stock Other $0 -1.38M -91.26% $0.00 133K Jul 18, 2022 By Blue Ox Healthcare Partners SP, LLC F1, F2
transaction SERA Class A Common Stock Other $0 -998K -92.8% $0.00 77.4K Jul 18, 2022 By BXHCP SP II, LLC F1, F2
transaction SERA Class A Common Stock Other $0 -1.16M -96.12% $0.00 46.7K Jul 18, 2022 By BXHCP SP III, LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Blue Ox Healthcare Partners, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.
F2 Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.